Lantheus Holdings, Inc. (LNTH): Price and Financial Metrics

Lantheus Holdings, Inc. (LNTH): $81.13

1.50 (-1.82%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

B

LNTH Price/Volume Stats

Current price $81.13 52-week high $94.47
Prev. close $82.63 52-week low $50.20
Day low $80.48 Volume 601,400
Day high $83.00 Avg. volume 985,062
50-day MA $74.03 Dividend yield N/A
200-day MA $66.10 Market Cap 5.62B

LNTH Stock Price Chart Interactive Chart >


Lantheus Holdings, Inc. (LNTH) Company Bio


Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. The company was founded in 1956 and is based in North Billerica, Massachusetts.


LNTH Latest News Stream


Event/Time News Detail
Loading, please wait...

LNTH Latest Social Stream


Loading social stream, please wait...

View Full LNTH Social Stream

Latest LNTH News From Around the Web

Below are the latest news stories about LANTHEUS HOLDINGS INC that investors may wish to consider to help them evaluate LNTH as an investment opportunity.

New Year, New Gains: The 3 Best AI Stocks to Buy in 2024

These AI stocks offer substantial upside potential compared to the overextended chip players that dominated the theme in 2023.

Omor Ibne Ehsan on InvestorPlace | January 1, 2024

13 Most Promising Future Stocks To Buy According To Hedge Funds

In this piece, we will take a look at the 13 most promising stocks to buy according to hedge funds. If you want to skip our overview of the latest stock market news, then you can take a look at the 5 Most Promising Future Stocks To Buy. Investing, for the most part, is all […]

Yahoo | December 27, 2023

Lantheus Holdings Is Charting a Path to Sustainable Growth and Value

Evaluating a leader in the global precision diagnostics market

Yahoo | December 20, 2023

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer

Phase 3 SPLASH study of 177Lu-PNT2002 demonstrated statistically significant improvement in radiographic progression-free survival (rPFS) BEDFORD, Mass., and INDIANAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- December 18, 2023 – Lantheus Holdings, Inc. (Lantheus) (NASDAQ: LNTH) and POINT Biopharma Global Inc. (POINT) (NASDAQ: PNT) today announced statistically significant topline results from the pivotal Phase 3 SPLASH study evaluating the efficacy and safety of 177Lu-PNT2002, a prostate-specific m

Yahoo | December 18, 2023

Lantheus Holdings (LNTH) Crossed Above the 200-Day Moving Average: What That Means for Investors

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?

Yahoo | December 15, 2023

Read More 'LNTH' Stories Here

LNTH Price Returns

1-mo -2.10%
3-mo 38.16%
6-mo 36.15%
1-year -12.64%
3-year 229.53%
5-year 191.31%
YTD 30.85%
2023 21.66%
2022 76.39%
2021 114.16%
2020 -34.23%
2019 31.05%

Continue Researching LNTH

Here are a few links from around the web to help you further your research on Lantheus Holdings Inc's stock as an investment opportunity:

Lantheus Holdings Inc (LNTH) Stock Price | Nasdaq
Lantheus Holdings Inc (LNTH) Stock Quote, History and News - Yahoo Finance
Lantheus Holdings Inc (LNTH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!